WASHINGTON (AP) The Food and Drug Administration commissioners effort to drastically shorten the review of drugs favored by President Donald Trumps administration is causing alarm across the agency, … [+9264 chars]
Legal questions swirl around FDA's new expedited drug program, including who should sign off - AP News
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been rocked by recent layoffs and resignations. Agency staffers and outside experts worry the FDA commissioner's voucher program runs afoul of …
By:Matthew Perrone
Source:Associated Press
Published:
Related News
Trump Tariff Threats Weigh on Asian Risk Appetite: Markets Wrap - Bloomberg.com
European and US stock futures fell and haven assets such as gold rallied after President Donald Trump proposed new levies on eight countries that have opposed his plans to acquire Greenland. The dollar weakened against most of its major peers.
Bloomberg•Anand Krishnamoorthy
Trump Tariff Threat to Weigh on Risk Sentiment, European Stocks - Bloomberg.com
US President Donald Trump’s announcement of new tariffs on eight European countries over Greenland weighed on risk sentiment as trading kicked off Monday.
Bloomberg•Farah Elbahrawy, Julien Ponthus
Sequoia to invest in Anthropic, breaking VC taboo on backing rivals: FT - TechCrunch
Sequoia Capital is reportedly joining a blockbuster funding round for Anthropic, the AI startup behind Claude, according to the Financial Times. It's a
TechCrunch•Connie Loizos